Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter? (2023)
Attributed to:
Evaluating new healthcare technologies in cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1055-9965.epi-22-1307
PubMed Identifier: 37259797
Publication URI: http://europepmc.org/abstract/MED/37259797
Type: Journal Article/Review
Volume: 32
Parent Publication: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Issue: 6
ISSN: 1055-9965